Market revenue in 2020 | USD 6.8 million |
Market revenue in 2028 | USD 12.5 million |
Growth rate | 7.9% (CAGR from 2020 to 2028) |
Largest segment | Simple generic |
Fastest growing segment | Biosimilars |
Historical data | 2018 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Simple Generic, Specialty Generics, Biosimilars |
Key market players worldwide | Teva Pharmaceutical Industries Ltd, Viatris Inc, Novartis AG ADR, Sun Pharmaceutical Industries, Lupin, AbbVie Inc, AstraZeneca PLC, Sawai Group Holdings Co Ltd, Hikma Pharmaceuticals PLC, Dr Reddy's Laboratories Ltd ADR, Cipla Ltd DR, Sanofi SA, Aurobindo Pharma, Endo Pharmaceuticals |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to generic pharmaceuticals market will help companies and investors design strategic landscapes.
Simple generic was the largest segment with a revenue share of 72.06% in 2020. Horizon Databook has segmented the Canada generic pharmaceuticals market based on simple generic, specialty generics, biosimilars covering the revenue growth of each sub-segment from 2018 to 2028.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada generic pharmaceuticals market , including forecasts for subscribers. This country databook contains high-level insights into Canada generic pharmaceuticals market from 2018 to 2028, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account